Navigation Links
Boston University School of Medicine researcher recipient of Memory Ride Grant
Date:9/10/2007

Boston Newton resident Benjamin Wolozin, MD, PhD, a professor of pharmacology at Boston University School of Medicine, was one of nine Massachusetts researchers to receive a 2007 Memory Ride Grant from the Alzheimers Association. Wolozin received a three-year investigator-initiated research grant for nearly $240,000 to study LRRK2 interactions with pathways linked to protein folding and degradation.

The LRRK2 gene provides instructions for making a protein called dardarin. The LRRK2 gene is active in the brain and other tissues throughout the body, but little is known about this gene or the dardarin protein. Mutations in LRRK2 are the most common genetic cause of Parkinsons Disease. Disease-related mutations in LRRK2 occur at many sites. The prevalence of LRRK2 mutations among subjects with Parkinsons Disease combined with the relevance to multiple types of pathologies emphasizes the importance of LRRK2, according to Wolozin.

Understanding the biology of LRRK2 will provide insight into pathological processes and novel therapeutic approaches for a broad range of neurodegenerative diseases, said Wolozin.

Wolozin serves as the primary investigator for several studies at the Boston University Alzheimers Disease Center. His interests focus on the pathophysiology of Alzheimers and Parkinsons diseases.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Page: 1

Related medicine news :

1. Measles Outbreak in Boston
2. Boston: Best Place For Having a Baby
3. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
4. Researchers at Cornell University as been reported using research fund by false claims
5. A new study by John Hopkins University proposes formula for good health
6. James Cook University urges more medical seats
7. Pill splitting program of University of Michigan can save money
8. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
9. Yale University guidelines for Physicians and Pharmaceutical industry
10. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
11. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... TX (PRWEB) , ... September 20, 2017 , ... ... date of the much-anticipated fall event , Look Awesome This Autumn with ... personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that Clear Global ... support services market) has entered into an agreement on September 1, 2017 with ... PGSD is the first private Dental School to launch an online, accredited Post ...
(Date:9/20/2017)... ... , ... Compliancy Group is proud to announce that its ... another long-time client pass their Department of Health and Human Services (HHS) Office ... to the help of the Compliancy Group's Audit Response Program™, not a single ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short ... has already been receiving positive feedback from customers trying the product for the first ... Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods ... market impact in 27 different categories. Nopavera Plus was named to the ... be announced at SupplySide West 2017 during presentations at SupplySide Central on Sept. 27 ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: